HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Entera Bio (NASDAQ:ENTX) and maintained a $10 price target, as stated by analyst Raghuram Selvaraju.
August 12, 2024 | 10:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Entera Bio and maintained a $10 price target, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to boost investor confidence in Entera Bio, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100